A carregar...
Publicação
An analysis of pharmaceutical industry pain points - the case of Italy
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 390.43 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This study identifies the problem areas of the pharmaceutical industry in three European
countries: Belgium, Italy, and Portugal. It examines the disparities in healthcare systems
between the countries and what difficulties they are experiencing in becoming more patient focused.
Some issues are common to the countries. Yet, they are weighed differently according to the
country's characteristics, mainly economic power. The pharmaceutical industry in Italy is a
robust and significant sector, with a strong emphasis on research and development, adherence
to stringent regulatory standards, global market presence through exports, and active
engagement in collaborations to drive innovation.
In general, these countries are making progress in prioritizing patients, paving the way for
personalized medicines and better disease management. These developments promise
substantial benefits in treatment outcomes.
Descrição
Palavras-chave
Healthcare Pharmaceutical industry Pain points Pricing and reimbursement Approval of medicines Measure of outcomes and value Pharmaceutical patents Sustainability Patient treatment compliance